Advanced search
Publication Cover
Cutaneous and Ocular Toxicology Volume 33, 2014 - Issue 3
Submit an article Journal homepage
311
Views
13
CrossRef citations to date
0
Altmetric
Case Reports

Topical henna ameliorated capecitabine-induced hand-foot syndrome

Saher IlyasSection of GI Cancers and Experimental Therapeutics, Tufts University School of Medicine Boston, MAUSA
,
Komal WasifSection of GI Cancers and Experimental Therapeutics, Tufts University School of Medicine Boston, MAUSA
&
Muhammad Wasif SaifSection of GI Cancers and Experimental Therapeutics, Tufts University School of Medicine Boston, MAUSACorrespondence[email protected]
Pages 253-255 | Received 30 Apr 2013, Accepted 31 Jul 2013, Published online: 11 Sep 2013

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Razieh Mohajerani, Farhad Shahi, Zahra Jafariazar & Minoo Afshar. (2021) Efficacy of topical Lawsonia inermis L. (Henna) hydrogel in fluorouracil-induced hand-foot syndrome: a pilot randomized double-blind placebo-controlled clinical trial. Cutaneous and Ocular Toxicology 40:3, pages 257-262.
Read now
V. Nikolaou, K. Syrigos & M. W. Saif. (2016) Incidence and implications of chemotherapy related hand-foot syndrome. Expert Opinion on Drug Safety 15:12, pages 1625-1633.
Read now

Articles from other publishers (11)

Jade Cury-Martins, Cristina Martinez Zugaib Abdalla & José Antonio Sanches. 2023. Oncodermatology. Oncodermatology 557 585 .
Mehdi Pasalar, Bahareh AhadiHamid Reza MirzaeiJudith BuentzelMojgan Mehri ArdestaniShaghayegh KamianGhazaleh Heydarirad. (2022) Comparing Dermolina-Henna Cream with Mometasone Cream in Improving Radiodermatitis Among Patients with Breast Cancer: A Randomized Active-Control Double-Blind Clinical Trial. Journal of Integrative and Complementary Medicine.
Crossref
Sepideh Elyasi, Sara Rasta, Ali Taghizadeh-Kermani & Sare Hosseini. (2022) Topical henna and curcumin (Alpha®) ointment efficacy for prevention of capecitabine induced hand-foot syndrome: A randomized, triple-blinded, placebo-controlled clinical. DARU Journal of Pharmaceutical Sciences 30:1, pages 117-125.
Crossref
Michalis Stavrinou, Theologia Tsitsi, George Astras, Lefkios Paikousis & Andreas Charalambous. (2021) A randomised controlled feasibility trial to evaluate Lawsonia inermis (henna)'s effect on palmar-plantar erythrodysesthesia induced by capecitabine or pegylated liposomal doxorubicin. European Journal of Oncology Nursing 51, pages 101908.
Crossref
Faraaz Zafar & Peter Lio. 2021. Dermato-Oncology Study Guide. Dermato-Oncology Study Guide 359 389 .
Selda Arslan, Pinar Zorba Bahceli, Yeter İlik & Mehmet Artaç. (2020) The preliminary effects of henna on chemotherapy-induced peripheral neuropathy in women receiving oxaliplatin-based treatment: A parallel-group, randomized, controlled pilot trial. European Journal of Oncology Nursing 48, pages 101827.
Crossref
Jade Cury-Martins, Adriana Pessoa Mendes Eris, Cristina Martinez Zugaib Abdalla, Giselle de Barros Silva, Veronica Paula Torel de Moura & Jose Antonio Sanches. (2020) Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel. Anais Brasileiros de Dermatologia 95:2, pages 221-237.
Crossref
Beina Zhang, Mao Shu, Chunmei Xu, Chunhong An, Rui Wang & Zhihua Lin. (2019) Virtual Screening, Docking, Synthesis and Bioactivity Evaluation of Thiazolidinediones as Potential PPARγ Partial Agonists for Preparation of Antidiabetic Agents. Letters in Drug Design & Discovery 16:6, pages 608-617.
Crossref
Sepideh Elyasi, Farzaneh Sadat Rezazadeh Shojaee, Abolghasem Allahyari & Gholamreza Karimi. (2017) Topical Silymarin Administration for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Phytotherapy Research 31:9, pages 1323-1329.
Crossref
Xiao-Hua Zhang, Shuai Hao, Bo Gao, Wu-Guo Tian, Yan Jiang, Shu Zhang, Ling-Ji Guo & Dong-Lin Luo. (2016) A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancer. Oncotarget 7:51, pages 84533-84543.
Crossref
. (2014) Capecitabine. Reactions Weekly 1520:1, pages 53-53.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.